High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$50.6M
$50,564,148
Total Sells (Filtered)
$521M
$521,983,601
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALKT
P
ALKAMI TECHNOLOGY, INC.
GENERAL ATLANTIC, L.P.
• Director
Discretionary Buy
2026-03-11
$16,569,000MEGA
|
||||||
| ALKT |
ALKAMI TECHNOLOGY, INC.
|
Director
Discretionary Buy
|
2026-03-11 | $16,569,000MEGA | P | Form 4 |
|
ALKT
P
ALKAMI TECHNOLOGY, INC.
GENERAL ATLANTIC, L.P.
• Director
Discretionary Buy
2026-03-10
$19,381,832MEGA
|
||||||
| ALKT |
ALKAMI TECHNOLOGY, INC.
|
Director
Discretionary Buy
|
2026-03-10 | $19,381,832MEGA | P | Form 4 |
|
ALKT
P
ALKAMI TECHNOLOGY, INC.
GENERAL ATLANTIC, L.P.
• Director
Discretionary Buy
2026-03-09
$14,613,315MEGA
|
||||||
| ALKT |
ALKAMI TECHNOLOGY, INC.
|
Director
Discretionary Buy
|
2026-03-09 | $14,613,315MEGA | P | Form 4 |
|
ALHC
S
Alignment Healthcare, Inc.
GENERAL ATLANTIC, L.P.
• 10% Owner
Discretionary SellΔOwn -45.2%
2025-12-12
$206,489,004MEGA
|
||||||
| ALHC |
Alignment Healthcare, Inc.
|
10% Owner
Discretionary SellΔOwn -45.2%
|
2025-12-12 | $206,489,004MEGA | S | Form 4 |
|
ALHC
S
Alignment Healthcare, Inc.
GENERAL ATLANTIC, L.P.
• Director
Discretionary SellΔOwn -20.2%
2025-09-17
$99,999,997MEGA
|
||||||
| ALHC |
Alignment Healthcare, Inc.
|
Director
Discretionary SellΔOwn -20.2%
|
2025-09-17 | $99,999,997MEGA | S | Form 4 |
|
ALHC
S
Alignment Healthcare, Inc.
GENERAL ATLANTIC, L.P.
• Director
Discretionary SellΔOwn -30.4%
2025-09-12
$215,494,600MEGA
|
||||||
| ALHC |
Alignment Healthcare, Inc.
|
Director
Discretionary SellΔOwn -30.4%
|
2025-09-12 | $215,494,600MEGA | S | Form 4 |